Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices

Hui-Yuen Joyce S.; Reddy Arthi; Taylor Jennifer; Li Xiaoqing; Eichenfield Andrew H.; Bermudez Liza M.; Starr Amy J.; Imundo Lisa F.; Buyon Jill; Furie Richard A.; Kamen Diane L.; Manzi Susan; Petri Michelle; Ramsey-Goldman Rosalind; van Vollenhoven Ronald F.; Wallace Daniel J.; Askanase Anca

首页> 外文期刊>The Journal of rheumatology >Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices

【24h】

Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices

机译：Belimumab在系统性临床实践中治疗系统性红斑狼疮的安全性和有效性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective. To evaluate the use and efficacy of belimumab in academic practices. Belimumab is a human monoclonal antibody that inhibits soluble B lymphocyte stimulator and has been approved for the treatment of adults with systemic lupus erythematosus (SLE).

机译：目的。评估贝利木单抗在学术实践中的使用和效果。 Belimumab是一种人单克隆抗体，可抑制可溶性B淋巴细胞刺激剂，已被批准用于治疗系统性红斑狼疮（SLE）的成人。

著录项

来源
《The Journal of rheumatology》 |2015年第12期|共8页
作者
Hui-Yuen Joyce S.; Reddy Arthi; Taylor Jennifer; Li Xiaoqing; Eichenfield Andrew H.; Bermudez Liza M.; Starr Amy J.; Imundo Lisa F.; Buyon Jill; Furie Richard A.; Kamen Diane L.; Manzi Susan; Petri Michelle; Ramsey-Goldman Rosalind; van Vollenhoven Ronald F.; Wallace Daniel J.; Askanase Anca;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
BELIMUMAB; SLE TREATMENT; CHILDHOOD-ONSET SLE; SYSTEMIC LUPUS ERYTHEMATOSUS;

机译：贝立木单抗;SLE治疗;儿童发作性SLE;系统性红斑狼疮;

相似文献

外文文献
中文文献
专利

1. Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices [J] . Hui-Yuen Joyce S., Reddy Arthi, Taylor Jennifer, The Journal of rheumatology . 2015,第12期

机译：Belimumab在系统性临床实践中治疗系统性红斑狼疮的安全性和有效性
2. Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan [J] . Patrick Muller, Kashfia Chowdhury, Caroline Gordon, Trials . 2020,第1期

机译：BELIMEAB在B细胞耗尽治疗中BELIMEAB在Systemic Lupus unerthematosus（Beat-Lupus）试验中的安全性和有效性：统计分析计划
3. BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus [J] . Woori Shin, Hyun Tae Lee, Heejin Lim, Nature Communications . 2018,第1期

机译：贝利木单抗的BAFF中和作用与其治疗系统性红斑狼疮的疗效有关
4. Systemic Lupus Erythematosus manifestation using ID3 algorithm - A clinical analysis [C] . Gomathi S., Narayani V. 2014 International Conference on Data Mining and Intelligent Computing . 2014

机译：使用ID3算法的系统性红斑狼疮表现-临床分析
5. Acquired Low Immunoglobulin Levels and Risk of Clinically Relevant Infection in Adult Patients with Systemic Lupus Erythematosus Cohort Study [D] . Almaghlouth, Ibrahim Ali S. 2019

机译：在成人狼疮患者中获得低免疫球蛋白水平和临床相关感染的风险红斑狼疮队列队列研究
6. Safety and efficacy of belimumab in systemic lupus erythematosus academic clinical practices [O] . Joyce S. Hui-Yuen, Arthi Reddy, Jennifer Taylor, -1

机译：贝利木单抗在系统性红斑狼疮学术临床实践中的安全性和有效性
7. Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study [O] . 2017

机译：在临床实践中接受贝利木单抗的系统性红斑狼疮患者的贝利木单抗使用，临床结局和糖皮质激素减少：OBSErve Canada研究的结果

Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices

摘要

著录项

相似文献

相关主题

期刊订阅